The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bicalutamide Market Research Report 2024
Synopsis
Bicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There is no pharmacodynamic or pharmacokinetic interaction with luteinizing hormone releasing hormone (LHRH) analogues.No interaction with common prescription drugs.No enzyme induction was observed at doses up to 150 mg per day.
The global Bicalutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bicalutamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bicalutamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bicalutamide include AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals and Accel Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bicalutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bicalutamide.
Report Scope
The Bicalutamide market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bicalutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bicalutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
CORDEN PHARMA GMBH
Zeneca GmbH
Actavis Pharma
Sivem Pharmaceuticals
Sorres Pharma
Fresenius Kabi
ANI Pharmaceuticals
Accel Pharma
Apotex Corporation
Shanghai Fudan Fuhua Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shanxi Zhendong Pharmaceutical
Segment by Type
Tablets
Capsule
Segment by Application
Single Drug For Prostate Cancer
Combined Chemotherapy For Prostate Cancer
Combined Radiation Therapy Or Castration For Prostate Cancer
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bicalutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bicalutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There is no pharmacodynamic or pharmacokinetic interaction with luteinizing hormone releasing hormone (LHRH) analogues.No interaction with common prescription drugs.No enzyme induction was observed at doses up to 150 mg per day.
The global Bicalutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bicalutamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bicalutamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bicalutamide include AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals and Accel Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bicalutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bicalutamide.
Report Scope
The Bicalutamide market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bicalutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bicalutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
CORDEN PHARMA GMBH
Zeneca GmbH
Actavis Pharma
Sivem Pharmaceuticals
Sorres Pharma
Fresenius Kabi
ANI Pharmaceuticals
Accel Pharma
Apotex Corporation
Shanghai Fudan Fuhua Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shanxi Zhendong Pharmaceutical
Segment by Type
Tablets
Capsule
Segment by Application
Single Drug For Prostate Cancer
Combined Chemotherapy For Prostate Cancer
Combined Radiation Therapy Or Castration For Prostate Cancer
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bicalutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bicalutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bicalutamide Market Overview
1.1 Product Overview and Scope of Bicalutamide
1.2 Bicalutamide Segment by Type
1.2.1 Global Bicalutamide Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.3 Bicalutamide Segment by Application
1.3.1 Global Bicalutamide Market Value by Application: (2024-2030)
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Global Bicalutamide Market Size Estimates and Forecasts
1.4.1 Global Bicalutamide Revenue 2019-2030
1.4.2 Global Bicalutamide Sales 2019-2030
1.4.3 Global Bicalutamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bicalutamide Market Competition by Manufacturers
2.1 Global Bicalutamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bicalutamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bicalutamide Average Price by Manufacturers (2019-2024)
2.4 Global Bicalutamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bicalutamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bicalutamide, Product Type & Application
2.7 Bicalutamide Market Competitive Situation and Trends
2.7.1 Bicalutamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bicalutamide Players Market Share by Revenue
2.7.3 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bicalutamide Retrospective Market Scenario by Region
3.1 Global Bicalutamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bicalutamide Global Bicalutamide Sales by Region: 2019-2030
3.2.1 Global Bicalutamide Sales by Region: 2019-2024
3.2.2 Global Bicalutamide Sales by Region: 2025-2030
3.3 Global Bicalutamide Global Bicalutamide Revenue by Region: 2019-2030
3.3.1 Global Bicalutamide Revenue by Region: 2019-2024
3.3.2 Global Bicalutamide Revenue by Region: 2025-2030
3.4 North America Bicalutamide Market Facts & Figures by Country
3.4.1 North America Bicalutamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bicalutamide Sales by Country (2019-2030)
3.4.3 North America Bicalutamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bicalutamide Market Facts & Figures by Country
3.5.1 Europe Bicalutamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bicalutamide Sales by Country (2019-2030)
3.5.3 Europe Bicalutamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bicalutamide Market Facts & Figures by Country
3.6.1 Asia Pacific Bicalutamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bicalutamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Bicalutamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bicalutamide Market Facts & Figures by Country
3.7.1 Latin America Bicalutamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bicalutamide Sales by Country (2019-2030)
3.7.3 Latin America Bicalutamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bicalutamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Bicalutamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bicalutamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bicalutamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bicalutamide Sales by Type (2019-2030)
4.1.1 Global Bicalutamide Sales by Type (2019-2024)
4.1.2 Global Bicalutamide Sales by Type (2025-2030)
4.1.3 Global Bicalutamide Sales Market Share by Type (2019-2030)
4.2 Global Bicalutamide Revenue by Type (2019-2030)
4.2.1 Global Bicalutamide Revenue by Type (2019-2024)
4.2.2 Global Bicalutamide Revenue by Type (2025-2030)
4.2.3 Global Bicalutamide Revenue Market Share by Type (2019-2030)
4.3 Global Bicalutamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bicalutamide Sales by Application (2019-2030)
5.1.1 Global Bicalutamide Sales by Application (2019-2024)
5.1.2 Global Bicalutamide Sales by Application (2025-2030)
5.1.3 Global Bicalutamide Sales Market Share by Application (2019-2030)
5.2 Global Bicalutamide Revenue by Application (2019-2030)
5.2.1 Global Bicalutamide Revenue by Application (2019-2024)
5.2.2 Global Bicalutamide Revenue by Application (2025-2030)
5.2.3 Global Bicalutamide Revenue Market Share by Application (2019-2030)
5.3 Global Bicalutamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Bicalutamide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 CORDEN PHARMA GMBH
6.2.1 CORDEN PHARMA GMBH Corporation Information
6.2.2 CORDEN PHARMA GMBH Description and Business Overview
6.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CORDEN PHARMA GMBH Bicalutamide Product Portfolio
6.2.5 CORDEN PHARMA GMBH Recent Developments/Updates
6.3 Zeneca GmbH
6.3.1 Zeneca GmbH Corporation Information
6.3.2 Zeneca GmbH Description and Business Overview
6.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zeneca GmbH Bicalutamide Product Portfolio
6.3.5 Zeneca GmbH Recent Developments/Updates
6.4 Actavis Pharma
6.4.1 Actavis Pharma Corporation Information
6.4.2 Actavis Pharma Description and Business Overview
6.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Pharma Bicalutamide Product Portfolio
6.4.5 Actavis Pharma Recent Developments/Updates
6.5 Sivem Pharmaceuticals
6.5.1 Sivem Pharmaceuticals Corporation Information
6.5.2 Sivem Pharmaceuticals Description and Business Overview
6.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sivem Pharmaceuticals Bicalutamide Product Portfolio
6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
6.6 Sorres Pharma
6.6.1 Sorres Pharma Corporation Information
6.6.2 Sorres Pharma Description and Business Overview
6.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sorres Pharma Bicalutamide Product Portfolio
6.6.5 Sorres Pharma Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Bicalutamide Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 ANI Pharmaceuticals
6.8.1 ANI Pharmaceuticals Corporation Information
6.8.2 ANI Pharmaceuticals Description and Business Overview
6.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ANI Pharmaceuticals Bicalutamide Product Portfolio
6.8.5 ANI Pharmaceuticals Recent Developments/Updates
6.9 Accel Pharma
6.9.1 Accel Pharma Corporation Information
6.9.2 Accel Pharma Description and Business Overview
6.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Accel Pharma Bicalutamide Product Portfolio
6.9.5 Accel Pharma Recent Developments/Updates
6.10 Apotex Corporation
6.10.1 Apotex Corporation Corporation Information
6.10.2 Apotex Corporation Description and Business Overview
6.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apotex Corporation Bicalutamide Product Portfolio
6.10.5 Apotex Corporation Recent Developments/Updates
6.11 Shanghai Fudan Fuhua Pharmaceutical
6.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
6.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Description and Business Overview
6.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolio
6.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
6.12 Shanghai Zhaohui Pharmaceutical
6.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
6.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Description and Business Overview
6.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolio
6.12.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Haizheng Pharmaceutical
6.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
6.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Description and Business Overview
6.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolio
6.13.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
6.14 Shanxi Zhendong Pharmaceutical
6.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
6.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Description and Business Overview
6.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolio
6.14.5 Shanxi Zhendong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bicalutamide Industry Chain Analysis
7.2 Bicalutamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bicalutamide Production Mode & Process
7.4 Bicalutamide Sales and Marketing
7.4.1 Bicalutamide Sales Channels
7.4.2 Bicalutamide Distributors
7.5 Bicalutamide Customers
8 Bicalutamide Market Dynamics
8.1 Bicalutamide Industry Trends
8.2 Bicalutamide Market Drivers
8.3 Bicalutamide Market Challenges
8.4 Bicalutamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bicalutamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bicalutamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bicalutamide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bicalutamide Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Bicalutamide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bicalutamide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bicalutamide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bicalutamide Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bicalutamide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bicalutamide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bicalutamide, Product Type & Application
Table 12. Global Key Manufacturers of Bicalutamide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bicalutamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bicalutamide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bicalutamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bicalutamide Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Bicalutamide Sales Market Share by Region (2019-2024)
Table 19. Global Bicalutamide Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Bicalutamide Sales Market Share by Region (2025-2030)
Table 21. Global Bicalutamide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bicalutamide Revenue Market Share by Region (2019-2024)
Table 23. Global Bicalutamide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bicalutamide Revenue Market Share by Region (2025-2030)
Table 25. North America Bicalutamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bicalutamide Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Bicalutamide Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Bicalutamide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bicalutamide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bicalutamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bicalutamide Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Bicalutamide Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Bicalutamide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bicalutamide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bicalutamide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bicalutamide Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Bicalutamide Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Bicalutamide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bicalutamide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bicalutamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bicalutamide Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Bicalutamide Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Bicalutamide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bicalutamide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bicalutamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bicalutamide Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Bicalutamide Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Bicalutamide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bicalutamide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bicalutamide Sales (M Pcs) by Type (2019-2024)
Table 51. Global Bicalutamide Sales (M Pcs) by Type (2025-2030)
Table 52. Global Bicalutamide Sales Market Share by Type (2019-2024)
Table 53. Global Bicalutamide Sales Market Share by Type (2025-2030)
Table 54. Global Bicalutamide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bicalutamide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bicalutamide Revenue Market Share by Type (2019-2024)
Table 57. Global Bicalutamide Revenue Market Share by Type (2025-2030)
Table 58. Global Bicalutamide Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Bicalutamide Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Bicalutamide Sales (M Pcs) by Application (2019-2024)
Table 61. Global Bicalutamide Sales (M Pcs) by Application (2025-2030)
Table 62. Global Bicalutamide Sales Market Share by Application (2019-2024)
Table 63. Global Bicalutamide Sales Market Share by Application (2025-2030)
Table 64. Global Bicalutamide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bicalutamide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bicalutamide Revenue Market Share by Application (2019-2024)
Table 67. Global Bicalutamide Revenue Market Share by Application (2025-2030)
Table 68. Global Bicalutamide Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Bicalutamide Price (US$/Pcs) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. AstraZeneca Bicalutamide Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. CORDEN PHARMA GMBH Corporation Information
Table 76. CORDEN PHARMA GMBH Description and Business Overview
Table 77. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. CORDEN PHARMA GMBH Bicalutamide Product
Table 79. CORDEN PHARMA GMBH Recent Developments/Updates
Table 80. Zeneca GmbH Corporation Information
Table 81. Zeneca GmbH Description and Business Overview
Table 82. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Zeneca GmbH Bicalutamide Product
Table 84. Zeneca GmbH Recent Developments/Updates
Table 85. Actavis Pharma Corporation Information
Table 86. Actavis Pharma Description and Business Overview
Table 87. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Actavis Pharma Bicalutamide Product
Table 89. Actavis Pharma Recent Developments/Updates
Table 90. Sivem Pharmaceuticals Corporation Information
Table 91. Sivem Pharmaceuticals Description and Business Overview
Table 92. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Sivem Pharmaceuticals Bicalutamide Product
Table 94. Sivem Pharmaceuticals Recent Developments/Updates
Table 95. Sorres Pharma Corporation Information
Table 96. Sorres Pharma Description and Business Overview
Table 97. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Sorres Pharma Bicalutamide Product
Table 99. Sorres Pharma Recent Developments/Updates
Table 100. Fresenius Kabi Corporation Information
Table 101. Fresenius Kabi Description and Business Overview
Table 102. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 103. Fresenius Kabi Bicalutamide Product
Table 104. Fresenius Kabi Recent Developments/Updates
Table 105. ANI Pharmaceuticals Corporation Information
Table 106. ANI Pharmaceuticals Description and Business Overview
Table 107. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 108. ANI Pharmaceuticals Bicalutamide Product
Table 109. ANI Pharmaceuticals Recent Developments/Updates
Table 110. Accel Pharma Corporation Information
Table 111. Accel Pharma Description and Business Overview
Table 112. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 113. Accel Pharma Bicalutamide Product
Table 114. Accel Pharma Recent Developments/Updates
Table 115. Apotex Corporation Corporation Information
Table 116. Apotex Corporation Description and Business Overview
Table 117. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 118. Apotex Corporation Bicalutamide Product
Table 119. Apotex Corporation Recent Developments/Updates
Table 120. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 121. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
Table 122. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 123. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product
Table 124. Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
Table 125. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 126. Shanghai Zhaohui Pharmaceutical Description and Business Overview
Table 127. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 128. Shanghai Zhaohui Pharmaceutical Bicalutamide Product
Table 129. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 130. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 131. Zhejiang Haizheng Pharmaceutical Description and Business Overview
Table 132. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 133. Zhejiang Haizheng Pharmaceutical Bicalutamide Product
Table 134. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
Table 135. Shanxi Zhendong Pharmaceutical Corporation Information
Table 136. Shanxi Zhendong Pharmaceutical Description and Business Overview
Table 137. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 138. Shanxi Zhendong Pharmaceutical Bicalutamide Product
Table 139. Shanxi Zhendong Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Bicalutamide Distributors List
Table 143. Bicalutamide Customers List
Table 144. Bicalutamide Market Trends
Table 145. Bicalutamide Market Drivers
Table 146. Bicalutamide Market Challenges
Table 147. Bicalutamide Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bicalutamide
Figure 2. Global Bicalutamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bicalutamide Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Bicalutamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bicalutamide Market Share by Application in 2023 & 2030
Figure 8. Single Drug For Prostate Cancer
Figure 9. Combined Chemotherapy For Prostate Cancer
Figure 10. Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 11. Global Bicalutamide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Bicalutamide Market Size (2019-2030) & (US$ Million)
Figure 13. Global Bicalutamide Sales (2019-2030) & (M Pcs)
Figure 14. Global Bicalutamide Average Price (US$/Pcs) & (2019-2030)
Figure 15. Bicalutamide Report Years Considered
Figure 16. Bicalutamide Sales Share by Manufacturers in 2023
Figure 17. Global Bicalutamide Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Bicalutamide Players: Market Share by Revenue in 2023
Figure 19. Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Bicalutamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Bicalutamide Sales Market Share by Country (2019-2030)
Figure 22. North America Bicalutamide Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Bicalutamide Sales Market Share by Country (2019-2030)
Figure 26. Europe Bicalutamide Revenue Market Share by Country (2019-2030)
Figure 27. Germany Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bicalutamide Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Bicalutamide Revenue Market Share by Region (2019-2030)
Figure 34. China Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Bicalutamide Sales Market Share by Country (2019-2030)
Figure 45. Latin America Bicalutamide Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Bicalutamide Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Bicalutamide Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Bicalutamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Bicalutamide by Type (2019-2030)
Figure 55. Global Revenue Market Share of Bicalutamide by Type (2019-2030)
Figure 56. Global Bicalutamide Price (US$/Pcs) by Type (2019-2030)
Figure 57. Global Sales Market Share of Bicalutamide by Application (2019-2030)
Figure 58. Global Revenue Market Share of Bicalutamide by Application (2019-2030)
Figure 59. Global Bicalutamide Price (US$/Pcs) by Application (2019-2030)
Figure 60. Bicalutamide Value Chain
Figure 61. Bicalutamide Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
